华东医院，原名上海市华东医院，是一家位于上海市的三级甲等综合性公立医院，主要承担高级领导干部、著名科技文艺界人士、外交官、外宾医疗保健，近年来也对市民开放。

During the past decade, Huadong Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Huadong Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Fudan University" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 1 trials sponsored and "Peking University" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Huadong Hospital" #1 collaborator was "Huadong Hospital" with 4 trials as a collaborator, "Sun Yat-sen University" with 2 trials as a collaborator, "Anhui Provincial Hospital" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Centers for Disease Control and Prevention, China" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Huadong Hospital" are "Esophageal Squamous Cell Carcinoma" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Respiratory Infection" (1 trials), "Angiotensin II Type 1 Receptor Blockers" (1 trials) and "Angiotensin-Converting Enzyme Inhibitors" (1 trials). Many other conditions were trialed in "Huadong Hospital" in a lesser frequency.

Most popular intervention types in "Huadong Hospital" are "Drug" (8 trials), "Other" (3 trials), "Device" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "3D-printed coplanar template" (1 trials), "3D-printed non-coplanar template" (1 trials), "Abiraterone Acetate" (1 trials) and "Acarbose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Huadong Hospital" are 15 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Huadong Hospital". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Huadong Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Huadong Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".